Quantitative reverse-transcriptase-polymerase-chain-reaction assay (Q-RT-PCR) showed lowered ARLTS1 expression in most of the clinical PCa samples, compared to BPH samples. Here, ARL11 is linked to benign prostatic hyperplasia.